It helps to reduce the high elimination rate in the drugs research and development process, and lays the foundation for the smooth launch of new drugs
The results of a study that has investigated the effect of riboflavin therapy on diabetic cardiomyopathy indicated that riboflavin can increase SOD activity in the heart tissue ( Reference Wang, Li and Lu 32 )
Clinical trials on patients with NAFLD have shown that probiotic supplementation can improve liver enzymes, reduce liver fat accumulation, and decrease systemic inflammation (112, 113)
Ladomersky E, Zhai L, Lauing KL, Bell A, Xu J, Kocherginsky M, Zhang B, Wu JD, Podojil JR, Platanias LC, Mochizuki AY, Prins RM, Kumthekar P, Raizer JJ, Dixit K, Lukas RV, Horbinski C, Wei M, Zhou C, Pawelec G, Campisi J, Grohmann U, Prendergast GC, Munn DH, Wainwright DA